Skip to main content
Premium Trial:

Request an Annual Quote

SphingoTec IB10 Sphingotest bio-ADM

SphingoTec launched IB10 Sphingotest bio-ADM, a CE IVD-marked point-of-care test to quantitatively determine blood levels of bioactive adrenomedullin. Blood levels of bio-ADM reflect the functional status of the endothelium, the inner cell sheet of blood vessels. The test is available on the company's rapid point-of-care platform Nexus IB10, which uses whole blood samples without pre-processing, requires less than three minutes of hands-on time, and delivers results in about 20 minutes.